Aesthetic medicine products. GSK ‘on track’ to divest consumer health business next year

Derma filler

THE WHAT? GlaxoSmithKline (GSK) has stated it is ‘firmly on track’ to sell its consumer health business next year, according to Reuters. 

THE DETAILS The company is reportedly likely to receive bids from private equity firms such as Advent, CVC and KKR, as well as large pharmaceutical and consumer goods companies. 

According to a Bloomberg News report, the unit, which makes Sensodyne toothpaste, could be valued at £40 billion (US$54 million) or more. 

Fat dissolving

THE WHY? GSK announced plans in June this year to turn the consumer arm into a separately listed company in order to focus on its under-performing drugs arm. 

A GSK spokesperson said, “The feedback we have received from our shareholders is that they are very keen to own the new Consumer Healthcare company as a listed entity through the demerger … The GSK board will fulfil its fiduciary duties to evaluate any alternative options.”

With the split on course to take place mid-2022, shareholders will receive stock in the new consumer health group to at least 80 percent of the 68 percent stake that GSK owns. 

Aesthetic medicine products are developed and regulated to meet stringent safety and efficacy standards. They are typically administered by trained healthcare professionals such as dermatologists, plastic surgeons, and specialized nurses in clinical settings. These products aim to provide effective solutions for cosmetic enhancement, skin rejuvenation, and overall aesthetic improvement, contributing to both physical appearance and self-confidence.

Key categories of aesthetic medicine products include:

  • Injectables: This category includes products such as dermal fillers, botulinum toxins (e.g., Botox), and collagen stimulators. These injectables are used to smooth wrinkles, add volume, and improve facial contours.

  • Skin Rejuvenation Treatments: Products like chemical peels, microdermabrasion systems, and laser devices are used to improve skin texture, reduce pigmentation irregularities, and enhance overall skin tone.

  • Skincare Products: These include medical-grade cleansers, moisturizers, serums, and topical treatments containing active ingredients like retinoids, antioxidants, and growth factors. They are formulated to address specific skin concerns such as acne, aging, and hyperpigmentation.

  • Hair Restoration Products: Medical treatments and products designed to promote hair growth and treat conditions such as male and female pattern baldness.

  • Body Contouring and Fat Reduction: Devices and products used for non-surgical body sculpting, such as cryolipolysis (cool sculpting) devices and injectable lipolytics.

  • Cosmeceuticals: High-performance skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing potent ingredients with proven clinical benefits.

  • Wound Care and Scar Management: Products like silicone sheets, gels, and advanced wound dressings used to improve healing and reduce the appearance of scars.

  Aesthetic medicine products. CVS set to shutter 900 stores over three-year period